中国
乙型肝炎
医学
环境卫生
梅德林
家庭医学
病毒学
政治学
法学
作者
Mehlika Toy,David W. Hutton,Jidong Jia,Samuel So
标识
DOI:10.7189/jogh.12.04043
摘要
Reaching the WHO 2030 with minimal delays would have an immense health and economic benefit. Implementing a national treatment program for HBV in China should be a key priority for policymakers.
科研通智能强力驱动
Strongly Powered by AbleSci AI